Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? Porcelli T, Luongo C, Cerbone A, Di Luccio C, et al. Eur Thyroid J 2025;14:e240332.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Porcelli T, Luongo C, Cerbone A, Di Luccio C, et al. Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? Eur Thyroid J 2025;14:e240332.
PMID: 39841677